Allogene Therapeutics (ALLO) Revenue (2021 - 2026)
Allogene Therapeutics (ALLO) posted Revenue of $22000.0 for Q1 2024, up 4.76% sequentially from $21000.0 in Q4 2023, and down 26.67% YoY from $30000.0 in Q2 2023.
Allogene Therapeutics (ALLO) Revenue (2021 - 2026) Analysis & Trends
Allogene Therapeutics has reported Revenue for 4 years, with the latest figure at $22000.0 in Q1 2024.
- Quarterly Revenue fell 26.67% year-over-year to $22000.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $22000.0 (down 76.84% YoY) and the FY2024 annual result came in at $22000.0, down 76.84% from the prior year.
- Revenue advanced to $22000.0 in Q1 2024 per ALLO's latest filing, from $21000.0 in the prior quarter.
- Over five years, Revenue peaked at $75.7 million in Q4 2021 and troughed at $21000.0 in Q4 2023.
- A 4-year average of $8.8 million and a median of $30000.0 in 2023 frame the typical range for Revenue.
- The widest YoY moves for Revenue: up 45.45% in 2022, down 99.97% in 2022.
- Over 4 years, Revenue stood at $75.7 million in 2021, then tumbled by 99.97% to $26000.0 in 2022, then dropped by 19.23% to $21000.0 in 2023, then rose by 4.76% to $22000.0 in 2024.
- According to Business Quant data, Revenue over the past three periods registered $22000.0, $21000.0, and $22000.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Allogene Therapeutics | 707.96 Mn | 707.96 Mn | - | 4.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.64 Mn |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Sep 30, 2022 | 27,000.00 |
| Jun 30, 2022 | 64,000.00 |
| Mar 31, 2022 | 39,000.00 |
| Dec 31, 2021 | 75.65 Mn |
| Sep 30, 2021 | 49,000.00 |
| Jun 30, 2021 | 44,000.00 |
| Mar 31, 2021 | 38.35 Mn |